Skip to main content

Table 1 Descriptive characteristics by breast cancer severity, including women from the AMORIS database 1989–2011

From: Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort

 

Any BC(N = 1824)

All BC w/severity (N = 1411)

Good (N = 900)

Moderate (N = 327)

Severe (N = 184)

N (%)

N(%)

N(%)

N(%)

N(%)

Age at Baseline (years)

  ≤ 49

810 (44.41)

632 (44.79)

405 (45.00)

133 (40.67)

94 (51.09)

 50–59

572 (31.36)

459 (32.43)

310 (34.44)

93 (28.44)

56 (30.43)

 60–69

308 (16.89)

235 (16.65)

140 (15.56)

69 (21.10)

26 (14.13)

  ≥ 70

134 (7.35)

85 (6.02)

45 (5.00)

32 (9.79)

8 (4.35)

Mean Interval (years)

 Time from baseline to BC (SD)

11.56 (6.46)

11.70 (6.52)

11.71 (6.42)

12.67 (6.85)

9.91 (6.06)

Parity

 Yes

1389 (76.15)

1072 (75.97)

682 (75.78)

246 (75.23)

144 (78.26)

 No

435 (23.85)

339 (24.03)

218 (24.22)

81 (24.77)

40 (21.74)

Socioeconomic Status

 High

747 (40.95)

594 (42.10)

397 (44.11)

128 (39.14)

69 (37.50)

 Low

895 (49.07)

689 (48.83)

432 (48.00)

160 (48.93)

97 (52.72)

 Unclassified/Missing

182 (9,98)

128 (9.07)

71 (7.89)

39 (11.93)

18 (9.78)

Fasting Status

 Fasting

1186 (65.02)

888 (62.93)

557 (61.89)

216 (66.06)

115 (62.50)

 Non-fasting

256 (14.04)

204 (14.46)

121 (13.44)

43 (13.15)

40 (21.74)

 Unknown

382 (20.94)

319 (22.61)

222 (24.67)

68 (20.80)

29 (15.76)

Tumour Side

 Left

759 (50.63)

701 (49.68)

440 (48.49)

168 (47.56)

93 (50.54)

 Right

740 (49.37)

674 (47.77)

428 (47.56)

159 (48.62)

87 (47.28)

 Missing

325 (17.82)

36 (2.55)

32 (3.56)

0 (0.00)

4 (11.11)

Invasive Gradea

 Grade 1

124 (6.80)

113 (8.01)

98 (10.89)

14 (4.28)

1 (0.54)

 Grade 2

296 (16.23)

280 (19.84)

178 (19.78)

93 (28.44)

9 (4.89)

 Grade 3

170 (9.32)

161 (11.41)

70 (7.78)

56 (17.13)

35 (19.02)

 Missing

1234 (67.65)

857 (60.74)

544 (61.56)

164 (50.15)

139 (75.54)

T-Stage

 T0: no evidence of primary tumour

23 (1.26)

21 (1.49)

17 (1.89)

1 (0.31)

3 (1.62)

 T1: ≤ 2 cm

1018 (55.81)

966 (68.46)

883 (98.11)

56 (17.13)

27 (14.67)

 T2: 2-5 cm

471 (25.82)

365 (25.87)

0 (0.00)

256 (78.29)

109 (59.24)

 T3: > 5 cm

36 (1.97)

21 (1.49)

0 (0.00)

14 (4.28)

7 (3.80)

 T4: tumour of any size with extension to the chest wall and/or skin

41 (2.25)

21 (1.49)

0 (0.00)

0 (0.00)

38 (20.65)

 TX: primary tumour cannot be assessed

235 (12.88)

38 (2.69)

0 (0.00)

0 (0.00)

0 (0.00)

N-Stage

 N0: negative

1332 (73.03)

1233 (87.38)

900 (100.00)

227 (69.42)

106 (57.61)

 N1: 1–3

226 (12.39)

167 (11.84)

0 (0.00)

100 (30.58)

67 (36.41)

 N2: 4–9

8 (0.44)

5 (0.35)

0 (0.00)

0 (0.00)

5 (2.72)

 N3: ≥ 19

7 (0.38)

6 (0.43)

0 (0.00)

0 (0.00)

6 (3.26)

 Nx: nodes cannot be assessed

251 (13.76)

0 (0.00)

0 (0.00)

0 (0.00)

0 (0.00)

M-Stage

 M0: no distant spread

1508 (82.68)

1390 (98.51)

900 (100.00)

327 (100.00)

163 (88.59)

 M1: spread to distant organs

22 (1.21)

21 (1.49)

0 (0.00)

0 (0.00)

21 (11.41)

 Mx: presence of metastasis cannot be assessed

294 (16.12)

0 (0.00)

0 (0.00)

0 (0.00)

0 (0.00)

Oestrogen Receptor Status

 Positive

1013 (55.54)

974 (69.03)

626 (69.56)

327 (100.00)

21 (11.41)

 Negative

220 (12.06)

213 (15.10)

87 (9.67)

0 (0.00)

126 (68.48)

 Missing

591 (32.40)

224 (15.88)

187 (20.78)

0 (0.00)

37 (20.11)

Progesterone Receptor Status

 Positive

839 (46.00)

811 (57.48)

531 (59.00)

246 (75.23)

34 (18.48)

 Negative

379 (20.78)

361 (25.58)

172 (19.11)

77 (23.55)

112 (60.87)

 Missing

606 (33.22)

239 (16.94)

197 (21.89)

4 (1.22)

38 (20.65)

HER2-status

 Positive

38 (2.08)

32 (2.27)

13 (1.44)

13 (3.98)

6 (3.26)

 Negative

289 (15.84)

264 (18.71)

172 (19.11)

71 (21.71)

21 (11.41)

 Missing

1497 (82.07)

1115 (79.02)

715 (79.44)

243 (74.31)

157 (85.33)

CCI

 0

1681 (92.16)

1306 (92.56)

834 (92.67)

302 (92.35)

170 (92.39)

 1

70 (3.84)

54 (3.83)

32 (3.56)

14 (4.28)

8 (4.35)

 2

54 (2.96)

35 (2.48)

24 (2.67)

8 (2.45)

3 (1.63)

 3+

19 (1.04)

16 (1.13)

10 (1.11)

3 (0.92)

3 (1.63)

Dead

 BC-Death

245 (13.43)

371 (26.29)

56 (6.22)

48 (14.68)

60 (32.61)

  1. aOnly diagnoses taken from the Breast Cancer Quality Register will have information available